Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

Critical Care Medicine

Volumn 29, Issue 6, 2001, Pages 1109-1115

  Ibrahim, Emad H ^a   Ward, Suzanne ^a   Sherman, Glenda ^b   Schaiff, Robyn ^b   Fraser, Victoria J ^a   Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Clinical outcomes; Critical care; Hospital mortality; Infection; Intensive care unit; Risk factors; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG UTILIZATION; EXPERIENCE; FEMALE; HUMAN; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; VENTILATOR;

EID: 0034979537     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200106000-00003     Document Type: Article

References (41)

1. Epidemiology of nosocomial pneumonia in intensive care unit patients
2. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
3. The prevention of ventilator-associated pneumonia
4. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies
5. Nosocomial pneumonia in the ICU - Year 2000 and beyond
6. Hospital-acquired pneumonia: Epidemiology, etiology, and treatment
7. Therapy for nosocomial pneumonia
8. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
9. Ventilator-associated bacterial pneumonia: Challenge in diagnosis, treatment, and prevention
10. Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients
11. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
12. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group
13. The value of routine microbial investigation in ventilator-associated pneumonia
14. The influence of mini-BAL cultures on patients outcomes: Implications for the antibiotic management of ventilator-associated pneumonia
15. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients
16. Rotation and restricted use of antibiotics in a medical intensive care unit: Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria
17. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices
18. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
19. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
20. Antibiotic resistance and production of extended-sputum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe
21. Impact of antimicrobial use on the epidemiology of nosocomial infections on the oncology ward: Implications for infection control
22. The APACHE II prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults
23. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid
24. Patient selection for clinical investigation of ventilator-associated pneumonia: Criteria for evaluating diagnostic techniques
25. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia
26. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia
27. The risk of determining risk with multivariable models
28. A computer-assisted management program for antibiotics and other antiinfective agents
29. Improving empiric antibiotic selection using computer decision support
30. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: A prospective analysis
31. Short course empiric antibiotic therapy for pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription
32. Infection-control measures reduce transmission of vancomycin-resistant enterocci in an endemic setting
33. Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
34. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership
35. Utility of transbronchial biopsy in patients with acute respiratory failure. A postmortem study
36. Reproducibility of the histologic diagnosis of pneumonia among a panel of four pathologists: Analysis of a gold standard
37. Histopathologic and microbiologic aspects of ventilator-associated pneumonia
38. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices
39. Rational empiric antibiotic prescription in the ICU: Clinical research is mandatory